Description: The life insurance industry is facing a rapidly changing landscape, with several emerging risks demanding the attention of actuaries and industry professionals. While actuaries commonly examine historical experience to guide our estimates of future outcomes, we are often faced with evidence that some of the forces that dictated past performance no longer persist and in some instances may even turn into contrary forces. This session aims to explore the key challenges and opportunities presented by risks with limited historical context, and discuss strategies to effectively manage them. We will delve into critical emerging risk areas, such as interest rate and asset risk, the rise of AI, climate change, predictive analytics in underwriting, and more. The session will feature speakers who are experts in managing risk, as well as results from interviews with top corporate risk professionals, such as CROs and ERM leads from major insurance and reinsurance companies. Attendees will gain valuable insights into emerging risks and practical strategies to navigate the evolving life insurance landscape.

Description: Session 7A: Integrated Analytics for GLP-1 Therapy Management: Optimizing Clinical and Financial Value

Description: CMS has required hospitals to publish their chargemaster rates, cash discounts and negotiated rates as of January 1, 2021. Our panel is comprised of a data strategist, an executive from a large hospital system and an actuary.

Description: Dana M. Peterson, chief economist for the Conference Board, has established herself as a visionary, and the go to expert providing insightful analysis and predictions to corporations, associations, and government organizations looking for clarity and foresight into how economic drivers might impact their businesses in the short- and long-term. With over two decades of experience in the field, she serves as the globally recognized think tank’s public face and primary spokesperson on all things related to the economy.

Description: This session will present the results of a case study investigating the impact of genetic testing on the reduction of health care costs. This will present both actuarial and clinical analysis of genetic testing in addition to researchers who are applying this approach.

Description: Reference Based Pricing (RBP) efforts have increased in popularity as tools to reduce the cost of care. Now with the ability to use CMS health plan transparency information, organizations can estimate the impact of savings from the use of RBP. This session will share the results of an analysis of this in the form of a case study.